Samsung Seoul Hospital to Host Korea-Japan Immunodeficiency Symposium

To Be Held at the Cancer Center on June 27
Sharing the Latest Research Findings

The Department of Pediatrics and Adolescent Medicine at Samsung Seoul Hospital announced on June 22 that it will host the "2026 Korea-Japan International Symposium on Immunodeficiency" at the Samsung Seoul Hospital Cancer Center in Gangnam-gu, Seoul, on June 27.

At this symposium, 13 experts from Korea and Japan in the field will give presentations, sharing the latest research trends and laying the groundwork for collaborative research between the two countries. Research supported by the Lee Kun-hee Pediatric Cancer and Rare Disease Project Group will also be presented.

Samsung Seoul Hospital Cancer Center. Samsung Seoul Hospital

During the morning session, participants will examine the mechanisms of cancer development in immunodeficiency patients and the limitations of current diagnostic approaches, while also presenting in-depth basic medical research findings, including personalized targeted therapies and the role of T cells in chronic inflammation. In the afternoon, the latest insights into antibody deficiencies and chronic granulomatous disease will be discussed, along with cutting-edge treatments aimed at fundamentally addressing rare immunological diseases, such as advancements in gene editing technologies and platforms.

The event is also expected to cover gene therapy research for "IKAROS deficiency." IKAROS deficiency was first introduced in Korea at the "2025 Korea-Japan Symposium on Congenital Immunodeficiency Diseases" and subsequently led to the first domestic patient being reported through the Korea Immunodeficiency Network (KINET).

Professor Kim Yejin of the Department of Pediatrics and Adolescent Medicine at Samsung Seoul Hospital stated, "For complex and rare diseases such as immunodeficiency, it is a critical time for close collaboration among clinical medicine, basic science, and genetics," adding, "We hope this event will serve as an opportunity to seek new hopes for treatment through active academic exchanges between the two countries."

This content was produced with the assistance of AI translation services.